| NCT ID | NCT07565454 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Methodist Health System |
| Condition | Gastro-Intestinal Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-04-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2021-04-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Some reports cite over 80% of surgery residency graduates are seeking additional training to improve on their experiences to be ready for practice. The Fellowship Council created several fellowship tracts including HPB (Hepato-Pancreato-Biliary),Advanced GI (gastrointestinal) and Minimally Invasive surgery to address this issue, and bridge the gap in training between residency and real life practice in those that seek a practice in HPB or complex GI surgery, respectively. By the end of fellowship, the core goal is to make the graduating fellows ready for independent practice in HPB or complex GI surgery cases.
Eligibility Criteria
Inclusion Criteria: 1. Current, and past fellows of Fellowship Council(FC )sponsored fellowship including Americas Hepato-Pancreato-Biliary Association(AHPBA)-accredited HPB and Advanced GI surgery fellowship. 2. Current senior surgeons involved in Fellowship Council(FC) fellowship training. Exclusion Criteria: Fellows who choose not to respond to the survey
Contact & Investigator
Rohan Jeyarajah, MD
PRINCIPAL INVESTIGATOR
Methodist Health System
Frequently Asked Questions
Who can join the NCT07565454 clinical trial?
This trial is open to participants of all sexes, studying Gastro-Intestinal Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07565454 currently recruiting?
Yes, NCT07565454 is actively recruiting participants. Contact the research team at ClinicalResearch@mhd.com for enrollment information.
Where is the NCT07565454 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT07565454 clinical trial?
NCT07565454 is sponsored by Methodist Health System. The principal investigator is Rohan Jeyarajah, MD at Methodist Health System. The trial plans to enroll 100 participants.